Published in CA Cancer J Clin on June 15, 1995
System for MR image-guided prostate interventions: canine study. Radiology (2003) 1.89
Differential expression of laminin 5 (alpha 3 beta 3 gamma 2) by human malignant and normal prostate. Am J Pathol (1996) 1.10
A focus group study of factors influencing African-American men's prostate cancer screening behavior. J Natl Med Assoc (2004) 1.04
Prostate cancer: here and now. CA Cancer J Clin (1995) 0.75
A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst (1998) 8.33
Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol (1999) 4.78
Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves. J Urol (1994) 3.17
Results of radical prostatectomy in men with clinically localized prostate cancer. JAMA (1996) 2.74
Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer. Br J Cancer (2010) 2.45
Factors predicting recovery of erections after radical prostatectomy. J Urol (2000) 2.44
Risk factors for urinary incontinence after radical prostatectomy. J Urol (1996) 2.42
Prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol (1995) 2.19
Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma. J Urol (1999) 2.00
Elevated expression of caveolin is associated with prostate and breast cancer. Clin Cancer Res (1998) 1.95
Vesicovaginal and ureterovaginal fistulas: a summary of 25 years of experience. J Urol (1980) 1.84
Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer. J Clin Oncol (2000) 1.80
Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer. Urology (2001) 1.76
Salvage radical prostatectomy: outcome measured by serum prostate specific antigen levels. J Urol (1995) 1.63
Pathological features and prognostic significance of prostate cancer in the apical section determined by whole mount histology. J Urol (1999) 1.54
Testicular metastasis as the first manifestation of colon carcinoma. J Urol (1988) 1.54
Future prospects in prostate cancer. Prostate (1999) 1.53
The pathological features and prognosis of prostate cancer detectable with current diagnostic tests. J Urol (1994) 1.53
Possible mechanism for seeding of tumor during radical prostatectomy. J Urol (1993) 1.52
A catalog of prostate cancer nomograms. J Urol (2001) 1.51
Evaluation of a nomogram used to predict the pathologic stage of clinically localized prostate carcinoma. Cancer (1997) 1.50
Heterogeneity of prostate cancer in radical prostatectomy specimens. Urology (1994) 1.48
Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging. Urology (2000) 1.44
The risk of distant metastases after transurethral resection of the prostate versus needle biopsy in patients with localized prostate cancer. J Urol (1989) 1.43
Hazard rates for progression after radical prostatectomy for clinically localized prostate cancer. Urology (1997) 1.41
A comparison of the morphological features of cancer arising in the transition zone and in the peripheral zone of the prostate. J Urol (1991) 1.40
Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer. J Urol (2000) 1.33
In situ gene therapy for adenocarcinoma of the prostate: a phase I clinical trial. Hum Gene Ther (1999) 1.26
Distinguishing clinically important from unimportant prostate cancers before treatment: value of systematic biopsies. J Urol (1996) 1.26
Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer. Hum Pathol (1998) 1.26
Transrectal ultrasound versus digital rectal examination for the staging of carcinoma of the prostate: results of a prospective, multi-institutional trial. J Urol (1997) 1.25
Has there been a recent shift in the pathological features and prognosis of patients treated with radical prostatectomy? J Urol (1997) 1.24
Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination. Urology (1993) 1.23
The value of serum tumor markers in the staging and prognosis of germ cell tumors of the testis. J Urol (1977) 1.23
The association of benign prostatic hyperplasia and cancer of the prostate. Cancer (1992) 1.22
Association of p53 mutations with metastatic prostate cancer. Clin Cancer Res (1995) 1.22
Prognostic significance of the diameter of perineural invasion in radical prostatectomy specimens. Hum Pathol (2001) 1.22
Impact of a clinical pathway for radical retropubic prostatectomy. Urology (1998) 1.20
NCCN Practice Guidelines for Prostate Cancer. Oncology (Williston Park) (2000) 1.19
Cellular localization of alpha-fetoprotein and human chorionic gonadotropin in germ cell tumors of the testis using and indirect immunoperoxidase technique. Cancer (1977) 1.18
Can radical prostatectomy alter the progression of poorly differentiated prostate cancer? J Urol (1994) 1.18
The New American Joint Committee on Cancer and International Union Against Cancer TNM classification of prostate cancer. Clinicopathologic correlations. Cancer (1994) 1.18
A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer screening in Rotterdam, Netherlands. Br J Cancer (2010) 1.16
A simple ileal substitute bladder after radical cystectomy: experience with a modification of the Studer pouch. J Urol (1995) 1.14
Assessment of the biologic markers p53, Ki-67, and apoptotic index as predictive indicators of prostate carcinoma recurrence after surgery. Cancer (1998) 1.13
Results of radical prostatectomy in men with locally advanced prostate cancer: multi-institutional pooled analysis. Eur Urol (1997) 1.11
Incidence, location, and significance of periprostatic and periseminal vesicle lymph nodes in prostate cancer. Am J Surg Pathol (2001) 1.10
Efficacy of antimicrobial-impregnated bladder catheters in reducing catheter-associated bacteriuria: a prospective, randomized, multicenter clinical trial. Urology (1999) 1.10
Prostate specific antigen and gleason grade: an immunohistochemical study of prostate cancer. J Urol (1994) 1.07
Frequency and location of extracapsular extension and positive surgical margins in radical prostatectomy specimens. J Urol (1992) 1.06
The appearance of prostate cancer on transrectal ultrasonography: correlation of imaging and pathological examinations. J Urol (1989) 1.06
Factors influencing morbidity in patients undergoing transurethral resection of the prostate. Urology (1999) 1.05
Suicide gene therapy toxicity after multiple and repeat injections in patients with localized prostate cancer. J Urol (2000) 1.04
Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones alone. Cancer (1983) 1.04
Fifteen-year survival and recurrence rates after radiotherapy for localized prostate cancer. J Clin Oncol (1997) 1.03
Primary Gleason pattern as a predictor of disease progression in gleason score 7 prostate cancer: a multivariate analysis of 823 men treated with radical prostatectomy. Am J Surg Pathol (2001) 1.03
Human chorionic gonadotropin detected in urinary concentrates from patients with malignant tumors of the testis, prostate, bladder, ureter and kidney. J Urol (1983) 1.03
Prognostic significance of lymph nodal metastases in prostate cancer. J Urol (1989) 1.03
Dietary fenretinide, a synthetic retinoid, decreases the tumor incidence and the tumor mass of ras+myc-induced carcinomas in the mouse prostate reconstitution model system. Cancer Res (1993) 1.02
Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies. Urology (1996) 1.01
Patterns of high-grade prostatic intraepithelial neoplasia associated with clinically aggressive prostate cancer. Hum Pathol (1998) 1.01
Risk factors for complications and morbidity after radical retropubic prostatectomy. J Urol (1997) 1.00
The mechanisms and prognostic significance of seminal vesicle involvement by prostate cancer. Am J Surg Pathol (1993) 0.99
Molecular mechanism of human CD38 gene expression by retinoic acid. Identification of retinoic acid response element in the first intron. J Biol Chem (1998) 0.99
Renal cell carcinoma with an infrarenal vena caval tumor thrombus. Urology (1999) 0.99
Accuracy of digital rectal examination and transrectal ultrasonography in localizing prostate cancer. J Urol (1994) 0.99
Elevated plasma chromogranin-A concentrations in prostatic carcinoma. J Urol (1991) 0.98
Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer. Lab Invest (1995) 0.98
Reduced levels of transforming growth factor beta receptor type II in human prostate cancer: an immunohistochemical study. Clin Cancer Res (1996) 0.97
Relevance of biochemical tumor markers and lymphadenectomy in management of non-seminomatous testis tumors: current perspective. J Urol (1980) 0.95
Frequency of apoptotic bodies positively correlates with Gleason grade in prostate cancer. Hum Pathol (1994) 0.95
The ratio of free to total serum prostate specific antigen and its use in differential diagnosis of prostate carcinoma in Japan. Cancer (1997) 0.95
Association of transforming growth factor-beta 1 with prostate cancer: an immunohistochemical study. Hum Pathol (1993) 0.95
The distribution of residual cancer in radical prostatectomy specimens in stage A prostate cancer. J Urol (1991) 0.94
Interposition of sural nerve restores function of cavernous nerves resected during radical prostatectomy. J Urol (1999) 0.93
Delivery of replication-competent retrovirus expressing Escherichia coli purine nucleoside phosphorylase increases the metabolism of the prodrug, fludarabine phosphate and suppresses the growth of bladder tumor xenografts. Cancer Gene Ther (2007) 0.93
Some small prostate cancers are nondiploid by nuclear image analysis: correlation of deoxyribonucleic acid ploidy status and pathological features. J Urol (1994) 0.92
Anatomy of the prostate and distribution of early prostate cancer. Semin Surg Oncol (1995) 0.91
Bilateral anterior ischemic optic neuropathy and branch retinal artery occlusion after radical prostatectomy. J Urol (1999) 0.91
Carcinoma arising in a branchial cleft cyst. Cancer (1976) 0.90
Transforming growth factor beta 1 as a biomarker for prostate cancer. J Cell Biochem Suppl (1992) 0.90
Perineural invasion of prostate carcinoma cells is associated with reduced apoptotic index. Cancer (1996) 0.90
Lymphovascular invasion as a predictor of disease progression in prostate cancer. Am J Surg Pathol (2000) 0.90